Yong Ren, Ph.D.
Director of Biology | Boston, Massachusetts, United States
Professional Overview
Yong Ren, Ph.D., is an accomplished Director of Biology with extensive expertise in the pharmaceutical industry. He specializes in leading cross-functional teams to drive innovative drug discovery and development programs, with a focus on in vitro pharmacology and target validation.
Experience Summary
Current Role
As the Director of Biology at Rectify Pharma, Yong is responsible for overseeing the company's biology research initiatives. He leads a team of scientists in the design, execution, and analysis of in vitro assays to support the identification and characterization of novel drug candidates. Yong's strategic leadership and technical expertise have been instrumental in advancing Rectify Pharma's pipeline of therapeutics targeting various disease areas.
Career Progression
Yong brings over 20 years of progressive experience in the pharmaceutical industry. Prior to his current role, he served as the Scientific Director at Eleusis, where he spearheaded the development of novel psychedelic-based therapeutics. Before that, Yong held positions as the Principal Scientist at Ohana Biosciences, Inc., Associate Director in vitro Pharmacology at Decibel Therapeutics, and Senior Principal Scientist/Lab Head at Pfizer. Throughout his career, Yong has made significant contributions to the advancement of drug discovery and development programs, with a proven track record of success.
Academic Background
Yong earned his Ph.D. in Molecular Biology from Tufts University, where he conducted groundbreaking research on cellular signaling pathways. He subsequently completed a post-doctoral fellowship at Tufts-New England Medical Center, further honing his expertise in in vitro pharmacology and target validation.
Areas of Expertise
- In vitro pharmacology and target validation
- Drug discovery and lead optimization
- Cellular and molecular biology
- Assay development and high-throughput screening
- Cross-functional team leadership and collaboration
- Strategic planning and project management
Professional Impact
Yong's work has been instrumental in the advancement of several drug candidates, contributing to the successful progression of multiple programs from the discovery phase to clinical development. His research has been published in prestigious peer-reviewed journals, and he is a sought-after speaker at industry conferences, sharing his insights and expertise with the broader scientific community.
Conclusion
With his extensive experience, technical proficiency, and strategic leadership, Yong Ren is poised to continue making significant contributions to the pharmaceutical industry. As the Director of Biology at Rectify Pharma, he is committed to driving innovation and delivering transformative therapies to improve patient outcomes.
